Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Diseases

Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.

598 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Diseases trial results

Completed

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

NCT02262455

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +68 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
View Trial Details
Completed

First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer

NCT01669226

Conditions
Adnexal Diseases, Bulky Stage IIIC and IV Epithelial Ovarian Cancer, Endocrine Gland Neoplasms, +17 more
Locations
  • Zhongda Hospital Southeast University Nanjing, Jiangsu, China
  • Suzhou Municipal Hospital Suzhou, Jiangsu, China
  • Wuxi Cancer Hospital Wuxi, Jiangsu, China
  • Shanghai Zhongshan Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Completed

S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00872989

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • NEA Medical Center - Stadium Boulevard Jonesboro, Arkansas, United States
View all 137 locations
View Trial Details
Completed

TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer

NCT01204749

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site San Diego, California, United States
  • Research Site Stanford, California, United States
View all 225 locations
View Trial Details
Completed

Collecting Tumor Samples From Patients With Gynecological Tumors

NCT00897442

Conditions
Adenoma, Adnexal Diseases, Borderline Ovarian Clear Cell Tumor, +143 more
Locations
  • Highlands Oncology Group PA - Fayetteville Fayetteville, Arkansas, United States
  • Washington Regional Medical Center - Fayetteville Fayetteville, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
View all 187 locations
View Trial Details
Completed

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

NCT01209195

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +28 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • Cancer Care Associates of Fresno Fresno, California, United States
View Trial Details

Related conditions